Melbourne Clinical Trials
The Digestion Study
The study drug is a potential new treatment for inflammatory bowel disease (IBD).
3 nights
2 visits
While the treatment of IBD has improved over the last 50 years and a large number of biologic treatments are available, none of them lead to significant clinical improvement and most of them lose effectiveness over time. This means patients need an increase in dose or must switch from one treatment to another. As a result, there is a need for new treatments for IBD.
The trial has been approved by an independent ethics committee and eligible participants will be reimbursed for their time.
Call us on 1800 243 733 to discuss your eligibility today!
Eligibility
Biological Sex Healthy males and females
Age 18 – 60 years old
BMI 18–32 kg/m2
Weight Female participants must weigh at least 45kg, male participants must weigh at least 50kg
Medication Not taking any medication
Medical History No significant medical history
Smoking History Non-smokers and casual smokers only (no more than 5 cigarettes per week)